P49116 (NR2C2_HUMAN) Reviewed, UniProtKB/Swiss-Prot
Last modified
May 29, 2013.
Version 126.
History...
Names·Attributes·General annotation·Ontologies·Alt products·Sequence annotation·Sequences·References·Cross-refs·Entry info·DocumentsCustomize order
Names·Attributes·General annotation·Ontologies·Alt products·Sequence annotation·Sequences·References·Cross-refs·Entry info·DocumentsCustomize orderNames and origin
| Protein names | Recommended name: Nuclear receptor subfamily 2 group C member 2 Alternative name(s): Orphan nuclear receptor TAK1 Orphan nuclear receptor TR4 Testicular receptor 4 | ||||
| Gene names |
| ||||
| Organism | Homo sapiens (Human) [Reference proteome] | ||||
| Taxonomic identifier | 9606 [NCBI] | ||||
| Taxonomic lineage | Eukaryota › Metazoa › Chordata › Craniata › Vertebrata › Euteleostomi › Mammalia › Eutheria › Euarchontoglires › Primates › Haplorrhini › Catarrhini › Hominidae › Homo![]() |
Protein attributes
| Sequence length | 596 AA. |
| Sequence status | Complete. |
| Protein existence | Evidence at protein level |
General annotation (Comments)
| Function | Orphan nuclear receptor that can act as a repressor or activator of transcription. An important repressor of nuclear recptor signaling pathways such as retinoic acid receptor, retinoid X, vitamin D3 receptor, thyroid hormone receptor and estrogen receptor pathways. May regulate gene expression during the late phase of spermatogenesis. Together with NR2C1, forms the core of the DRED (direct repeat erythroid-definitive) complex that represses embryonic and fetal globin transcription including that of GATA1. Binds to hormone response elements (HREs) consisting of two 5'-AGGTCA-3' half site direct repeat consensus sequences. Plays a fundamental role in early embryonic development and embryonic stem cells. Required for normal spermatogenesis and cerebellum development. Appears to be important for neurodevelopmentally regulated behavior By similarity. Activates transcriptional activity of LHCG. Antagonist of PPARA-mediated transactivation. Ref.7 Ref.8 Ref.9 Ref.10 Ref.12 |
| Subunit structure | Homodimer; can bind DNA as homodimer By similarity. Heterodimer; binds DNA as a heterodimer with NR2C1 required for chromatin remodeling and for binding to promoter regions such as globin DR1 repeats. Interacts with PCAF; the interaction preferentially occurs on the non-phosphorylated form and induces NR2C2-mediated transactivation activity and does not require the ligand-binding domain. Interacts (MAPK-mediated phosphorylated form) with NRIP1; the interaction promotes repression of NR2C2-mediated activity By similarity. Interacts with NR2C2AP; the interaction represses selective NR2C2-mediated transcriptional activity. Interacts with NLRP10. Ref.8 Ref.11 Ref.12 Ref.17 |
| Subcellular location | |
| Developmental stage | Transiently repressed during the meiotic phase of spermatogenesis. |
| Induction | Induced by oxidative stress via FOXO3 activation. Ref.13 |
| Post-translational modification | Phosphorylation on Ser-19 and Ser-68 is an important regulator of NR2C2-mediated transcriptional activity. Phosphorylation on these residues recruits the corepressor, NRIP1, leading to transcripional repression, whereas the non-phosphorylated form preferentially recruits the coactivator, PCAF By similarity. |
| Sequence similarities | Belongs to the nuclear hormone receptor family. NR2 subfamily. Contains 1 nuclear receptor DNA-binding domain. |
Ontologies
Alternative products
| This entry describes 2 isoforms produced by alternative splicing. [Align] [Select] | ||||||
| Isoform 1 (identifier: P49116-1) This isoform has been chosen as the 'canonical' sequence. All positional information in this entry refers to it. This is also the sequence that appears in the downloadable versions of the entry. | ||||||
| Isoform 2 (identifier: P49116-2) The sequence of this isoform differs from the canonical sequence as follows: 24-24: Q → QGSEPASGPLSVFTSLNKEK |
Sequence annotation (Features)
| Feature key | Position(s) | Length | Description | Graphical view | Feature identifier | |||||||||||||||||||||||||||||||||
Molecule processing | ||||||||||||||||||||||||||||||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Chain | 1 – 596 | 596 | Nuclear receptor subfamily 2 group C member 2 | PRO_0000053588 | ||||||||||||||||||||||||||||||||||
Regions | ||||||||||||||||||||||||||||||||||||||
| DNA binding | 114 – 189 | 76 | Nuclear receptor Ref.3 Ref.7 Ref.8 Ref.9 | |||||||||||||||||||||||||||||||||||
| Zinc finger | 117 – 137 | 21 | NR C4-type | |||||||||||||||||||||||||||||||||||
| Zinc finger | 153 – 177 | 25 | NR C4-type | |||||||||||||||||||||||||||||||||||
| Region | 388 – 554 | 167 | Ligand-binding By similarity | |||||||||||||||||||||||||||||||||||
Amino acid modifications | ||||||||||||||||||||||||||||||||||||||
| Modified residue | 19 | 1 | Phosphoserine; by MAPK Ref.15 Ref.16 | |||||||||||||||||||||||||||||||||||
| Modified residue | 46 | 1 | Phosphoserine Ref.15 Ref.16 | |||||||||||||||||||||||||||||||||||
| Modified residue | 55 | 1 | Phosphoserine; by MAPK By similarity | |||||||||||||||||||||||||||||||||||
| Modified residue | 68 | 1 | Phosphoserine; by MAPK Ref.16 | |||||||||||||||||||||||||||||||||||
| Modified residue | 98 | 1 | Phosphoserine Ref.16 | |||||||||||||||||||||||||||||||||||
| Modified residue | 219 | 1 | Phosphoserine Ref.14 Ref.16 | |||||||||||||||||||||||||||||||||||
Natural variations | ||||||||||||||||||||||||||||||||||||||
| Alternative sequence | 24 | 1 | Q → QGSEPASGPLSVFTSLNKEK in isoform 2. | VSP_039522 | ||||||||||||||||||||||||||||||||||
Experimental info | ||||||||||||||||||||||||||||||||||||||
| Sequence conflict | 108 | 1 | V → A in BAH02299. Ref.3 | |||||||||||||||||||||||||||||||||||
| Sequence conflict | 156 | 1 | N → S in AAA21474. Ref.2 | |||||||||||||||||||||||||||||||||||
| Sequence conflict | 326 | 1 | S → F in BAH02299. Ref.3 | |||||||||||||||||||||||||||||||||||
| Sequence conflict | 400 | 1 | W → R in AAA21474. Ref.2 | |||||||||||||||||||||||||||||||||||
| Sequence conflict | 409 | 1 | A → G in AAA21474. Ref.2 | |||||||||||||||||||||||||||||||||||
| Sequence conflict | 484 – 485 | 2 | KL → NW in AAA21474. Ref.2 | |||||||||||||||||||||||||||||||||||
| Sequence conflict | 594 | 1 | A → V in AAA21474. Ref.2 | |||||||||||||||||||||||||||||||||||
| Sequence conflict | 594 | 1 | A → V in BAH02299. Ref.3 | |||||||||||||||||||||||||||||||||||
Secondary structure | ||||||||||||||||||||||||||||||||||||||
Helix Strand Turn | ||||||||||||||||||||||||||||||||||||||
| Beta strand | 354 – 357 | 4 | ||||||||||||||||||||||||||||||||||||
| Helix | 386 – 402 | 17 | ||||||||||||||||||||||||||||||||||||
| Turn | 405 – 407 | 3 | ||||||||||||||||||||||||||||||||||||
| Helix | 408 – 410 | 3 | ||||||||||||||||||||||||||||||||||||
| Helix | 412 – 420 | 9 | ||||||||||||||||||||||||||||||||||||
| Helix | 423 – 433 | 11 | ||||||||||||||||||||||||||||||||||||
| Turn | 434 – 436 | 3 | ||||||||||||||||||||||||||||||||||||
| Helix | 468 – 484 | 17 | ||||||||||||||||||||||||||||||||||||
| Helix | 489 – 500 | 12 | ||||||||||||||||||||||||||||||||||||
| Helix | 512 – 532 | 21 | ||||||||||||||||||||||||||||||||||||
| Turn | 533 – 535 | 3 | ||||||||||||||||||||||||||||||||||||
| Helix | 539 – 544 | 6 | ||||||||||||||||||||||||||||||||||||
| Helix | 547 – 551 | 5 | ||||||||||||||||||||||||||||||||||||
| Helix | 555 – 562 | 8 | ||||||||||||||||||||||||||||||||||||
| Helix | 567 – 570 | 4 | ||||||||||||||||||||||||||||||||||||
| Helix | 572 – 579 | 8 | ||||||||||||||||||||||||||||||||||||
Sequences
| ||||||||||||||||||||||||
References
| « Hide 'large scale' references | |
| [1] | "TAK1: molecular cloning and characterization of a new member of the nuclear receptor superfamily." Hirose T., Fujimoto W., Yamaai T., Kim K.H., Matsuura H., Jetten A.M. Mol. Endocrinol. 8:1667-1680(1994) [PubMed] [Europe PMC] [Abstract] Cited for: NUCLEOTIDE SEQUENCE [MRNA] (ISOFORM 1). Tissue: Testis. |
| [2] | "Human and rat TR4 orphan receptors specify a subclass of the steroid receptor superfamily." Chang C., da Silva S.L., Ideta R., Lee Y., Yeh S., Burbach J.P. Proc. Natl. Acad. Sci. U.S.A. 91:6040-6044(1994) [PubMed] [Europe PMC] [Abstract] Cited for: NUCLEOTIDE SEQUENCE [MRNA] (ISOFORM 2). Tissue: Prostate and Testis. |
| [3] | "DNA-binding profiling of human hormone nuclear receptors via fluorescence correlation spectroscopy in a cell-free system." Kobayashi T., Kodani Y., Nozawa A., Endo Y., Sawasaki T. FEBS Lett. 582:2737-2744(2008) [PubMed] [Europe PMC] [Abstract] Cited for: NUCLEOTIDE SEQUENCE [MRNA] (ISOFORM 1), DNA-BINDING SPECIFICITY. |
| [4] | "Complete sequencing and characterization of 21,243 full-length human cDNAs." Ota T., Suzuki Y., Nishikawa T., Otsuki T., Sugiyama T., Irie R., Wakamatsu A., Hayashi K., Sato H., Nagai K., Kimura K., Makita H., Sekine M., Obayashi M., Nishi T., Shibahara T., Tanaka T., Ishii S. Sugano S.Nat. Genet. 36:40-45(2004) [PubMed] [Europe PMC] [Abstract] Cited for: NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA] (ISOFORM 1). |
| [5] | "The DNA sequence, annotation and analysis of human chromosome 3." Muzny D.M., Scherer S.E., Kaul R., Wang J., Yu J., Sudbrak R., Buhay C.J., Chen R., Cree A., Ding Y., Dugan-Rocha S., Gill R., Gunaratne P., Harris R.A., Hawes A.C., Hernandez J., Hodgson A.V., Hume J. Gibbs R.A.Nature 440:1194-1198(2006) [PubMed] [Europe PMC] [Abstract] Cited for: NUCLEOTIDE SEQUENCE [LARGE SCALE GENOMIC DNA]. |
| [6] | Mural R.J., Istrail S., Sutton G.G., Florea L., Halpern A.L., Mobarry C.M., Lippert R., Walenz B., Shatkay H., Dew I., Miller J.R., Flanigan M.J., Edwards N.J., Bolanos R., Fasulo D., Halldorsson B.V., Hannenhalli S., Turner R. Venter J.C.Submitted (JUL-2005) to the EMBL/GenBank/DDBJ databases Cited for: NUCLEOTIDE SEQUENCE [LARGE SCALE GENOMIC DNA]. |
| [7] | "The orphan receptor TAK1 acts as a repressor of RAR-, RXR- and T3R-mediated signaling pathways." Hirose T., Apfel R., Pfahl M., Jetten A.M. Biochem. Biophys. Res. Commun. 211:83-91(1995) [PubMed] [Europe PMC] [Abstract] Cited for: DNA-BINDING, FUNCTION. |
| [8] | "Regulation of peroxisome proliferator-activated receptor alpha-induced transactivation by the nuclear orphan receptor TAK1/TR4." Yan Z.H., Karam W.G., Staudinger J.L., Medvedev A., Ghanayem B.I., Jetten A.M. J. Biol. Chem. 273:10948-10957(1998) [PubMed] [Europe PMC] [Abstract] Cited for: DNA-BINDING, INTERACTION WITH NRIP1, FUNCTION. |
| [9] | "Differential regulation of direct repeat 3 vitamin D3 and direct repeat 4 thyroid hormone signaling pathways by the human TR4 orphan receptor." Lee Y.F., Young W.J., Lin W.J., Shyr C.R., Chang C. J. Biol. Chem. 274:16198-16205(1999) [PubMed] [Europe PMC] [Abstract] Cited for: DNA-BINDING, FUNCTION. |
| [10] | "Nuclear orphan receptors regulate transcription of the gene for the human luteinizing hormone receptor." Zhang Y., Dufau M.L. J. Biol. Chem. 275:2763-2770(2000) [PubMed] [Europe PMC] [Abstract] Cited for: FUNCTION, SUBCELLULAR LOCATION. |
| [11] | "Identification of a novel testicular orphan receptor-4 (TR4)-associated protein as repressor for the selective suppression of TR4-mediated transactivation." Yang Y., Wang X., Dong T., Kim E., Lin W.-J., Chang C. J. Biol. Chem. 278:7709-7717(2003) [PubMed] [Europe PMC] [Abstract] Cited for: INTERACTION WITH NR2C2AP. |
| [12] | "The TR2 and TR4 orphan nuclear receptors repress Gata1 transcription." Tanabe O., Shen Y., Liu Q., Campbell A.D., Kuroha T., Yamamoto M., Engel J.D. Genes Dev. 21:2832-2844(2007) [PubMed] [Europe PMC] [Abstract] Cited for: HETERODIMERIZATION, FUNCTION. |
| [13] | "Oxidative stress stimulates testicular orphan receptor 4 through forkhead transcription factor forkhead box O3a." Li G., Lee Y.F., Liu S., Cai Y., Xie S., Liu N.C., Bao B.Y., Chen Z., Chang C. Endocrinology 149:3490-3499(2008) [PubMed] [Europe PMC] [Abstract] Cited for: INDUCTION. |
| [14] | "A quantitative atlas of mitotic phosphorylation." Dephoure N., Zhou C., Villen J., Beausoleil S.A., Bakalarski C.E., Elledge S.J., Gygi S.P. Proc. Natl. Acad. Sci. U.S.A. 105:10762-10767(2008) [PubMed] [Europe PMC] [Abstract] Cited for: PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-219, MASS SPECTROMETRY. Tissue: Cervix carcinoma. |
| [15] | "Quantitative phosphoproteomic analysis of T cell receptor signaling reveals system-wide modulation of protein-protein interactions." Mayya V., Lundgren D.H., Hwang S.-I., Rezaul K., Wu L., Eng J.K., Rodionov V., Han D.K. Sci. Signal. 2:RA46-RA46(2009) [PubMed] [Europe PMC] [Abstract] Cited for: PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-19 AND SER-46, MASS SPECTROMETRY. Tissue: Leukemic T-cell. |
| [16] | "Quantitative phosphoproteomics reveals widespread full phosphorylation site occupancy during mitosis." Olsen J.V., Vermeulen M., Santamaria A., Kumar C., Miller M.L., Jensen L.J., Gnad F., Cox J., Jensen T.S., Nigg E.A., Brunak S., Mann M. Sci. Signal. 3:RA3-RA3(2010) [PubMed] [Europe PMC] [Abstract] Cited for: PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-19; SER-46; SER-68; SER-98 AND SER-219, MASS SPECTROMETRY. Tissue: Cervix carcinoma. |
| [17] | "NLRP10 enhances Shigella-induced pro-inflammatory responses." Lautz K., Damm A., Menning M., Wenger J., Adam A.C., Zigrino P., Kremmer E., Kufer T.A. Cell. Microbiol. 14:1568-1583(2012) [PubMed] [Europe PMC] [Abstract] Cited for: INTERACTION WITH NLRP10. |
| + | Additional computationally mapped references. |
Cross-references
Sequence databases | |||||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| EMBL GenBank DDBJ | U10990 mRNA. Translation: AAC50118.1. L27586 mRNA. Translation: AAA21474.1. AB307708 mRNA. Translation: BAH02299.1. AK290590 mRNA. Translation: BAF83279.1. AC090937 Genomic DNA. No translation available. AC090954 Genomic DNA. No translation available. CH471055 Genomic DNA. Translation: EAW64215.1. | ||||||||||||
| IPI | IPI00332451. IPI00749258. | ||||||||||||
| PIR | A57031. I59309. | ||||||||||||
| RefSeq | NP_003289.2. NM_003298.3. | ||||||||||||
| UniGene | Hs.555973. | ||||||||||||
3D structure databases | |||||||||||||
| PDBe RCSB PDB PDBj |
| ||||||||||||
| ProteinModelPortal | P49116. | ||||||||||||
| ModBase | Search... | ||||||||||||
Protein-protein interaction databases | |||||||||||||
| DIP | DIP-5999N. | ||||||||||||
| IntAct | P49116. 2 interactions. | ||||||||||||
| MINT | MINT-7004540. | ||||||||||||
| STRING | 9606.ENSP00000320447. | ||||||||||||
PTM databases | |||||||||||||
| PhosphoSite | P49116. | ||||||||||||
Polymorphism databases | |||||||||||||
| DMDM | 1351190. | ||||||||||||
Proteomic databases | |||||||||||||
| PaxDb | P49116. | ||||||||||||
| PRIDE | P49116. | ||||||||||||
Protocols and materials databases | |||||||||||||
| DNASU | 7182. | ||||||||||||
| StructuralBiologyKnowledgebase | Search... | ||||||||||||
Genome annotation databases | |||||||||||||
| Ensembl | ENST00000323373; ENSP00000320447; ENSG00000177463. ENST00000393102; ENSP00000376814; ENSG00000177463. ENST00000406272; ENSP00000384463; ENSG00000177463. ENST00000425241; ENSP00000388387; ENSG00000177463. | ||||||||||||
| GeneID | 7182. | ||||||||||||
| KEGG | hsa:7182. | ||||||||||||
| UCSC | uc003bzj.4. human. | ||||||||||||
Organism-specific databases | |||||||||||||
| CTD | 7182. | ||||||||||||
| GeneCards | GC03P014989. | ||||||||||||
| HGNC | HGNC:7972. NR2C2. | ||||||||||||
| HPA | HPA006313. | ||||||||||||
| MIM | 601426. gene. | ||||||||||||
| neXtProt | NX_P49116. | ||||||||||||
| PharmGKB | PA31755. | ||||||||||||
| GenAtlas | Search... | ||||||||||||
Phylogenomic databases | |||||||||||||
| eggNOG | NOG297520. | ||||||||||||
| HOGENOM | HOG000013058. | ||||||||||||
| HOVERGEN | HBG008596. | ||||||||||||
| KO | K08544. | ||||||||||||
| OMA | KADVQRP. | ||||||||||||
| OrthoDB | EOG4Z36D8. | ||||||||||||
Enzyme and pathway databases | |||||||||||||
| Pathway_Interaction_DB | ar_tf_pathway. Regulation of Androgen receptor activity. | ||||||||||||
| Reactome | REACT_71. Gene Expression. | ||||||||||||
| SignaLink | P49116. | ||||||||||||
Gene expression databases | |||||||||||||
| ArrayExpress | P49116. | ||||||||||||
| Bgee | P49116. | ||||||||||||
| CleanEx | HS_NR2C2. | ||||||||||||
| Genevestigator | P49116. | ||||||||||||
| GermOnline | ENSG00000177463. Homo sapiens. | ||||||||||||
Family and domain databases | |||||||||||||
| Gene3D | 1.10.565.10. 3 hits. 3.30.50.10. 1 hit. | ||||||||||||
| InterPro | IPR008946. Nucl_hormone_rcpt_ligand-bd. IPR000536. Nucl_hrmn_rcpt_lig-bd_core. IPR001723. Str_hrmn_rcpt. IPR001628. Znf_hrmn_rcpt. IPR013088. Znf_NHR/GATA. [Graphical view] | ||||||||||||
| Pfam | PF00104. Hormone_recep. 1 hit. PF00105. zf-C4. 1 hit. [Graphical view] | ||||||||||||
| PRINTS | PR00398. STRDHORMONER. PR00047. STROIDFINGER. | ||||||||||||
| SMART | SM00430. HOLI. 1 hit. SM00399. ZnF_C4. 1 hit. [Graphical view] | ||||||||||||
| SUPFAM | SSF48508. Str_ncl_receptor. 1 hit. | ||||||||||||
| PROSITE | PS00031. NUCLEAR_REC_DBD_1. 1 hit. PS51030. NUCLEAR_REC_DBD_2. 1 hit. [Graphical view] | ||||||||||||
| ProtoNet | Search... | ||||||||||||
Other | |||||||||||||
| BindingDB | P49116. | ||||||||||||
| ChEMBL | CHEMBL5716. | ||||||||||||
| ChiTaRS | NR2C2. human. | ||||||||||||
| EvolutionaryTrace | P49116. | ||||||||||||
| GenomeRNAi | 7182. | ||||||||||||
| NextBio | 28158. | ||||||||||||
| SOURCE | Search... | ||||||||||||
Entry information
| Entry name | NR2C2_HUMAN | ||||||||
| Accession | Primary (citable) accession number: P49116 Secondary accession number(s): A8K3H5, B6ZGT8, P55092 | ||||||||
| Entry history |
| ||||||||
| Entry status | Reviewed (UniProtKB/Swiss-Prot) | ||||||||
| Annotation program | Chordata Protein Annotation Program | ||||||||
| Disclaimer | Any medical or genetic information present in this entry is provided for research, educational and informational purposes only. It is not in any way intended to be used as a substitute for professional medical advice, diagnosis, treatment or care. | ||||||||
Relevant documents
| Human chromosome 3 Human chromosome 3: entries, gene names and cross-references to MIM |
| MIM cross-references Online Mendelian Inheritance in Man (MIM) cross-references in UniProtKB/Swiss-Prot |
| PDB cross-references Index of Protein Data Bank (PDB) cross-references |
| SIMILARITY comments Index of protein domains and families |

Clusters with
